Search results

101. IgLON5 disease: NeuroInflammatory Tauopathy and Encephalopathy: the Model for Inflammation towards early treatment of Ne…

Principal investigator: dr Natalia Eleonora Małek-Chudzik

Politechnika Wrocławska

Call: JPND Call 2024, Panel: NZ4

102. Autophagy stimulation by genistein to cure Alzheimer disease: mechanisms and effects investigated using genetic (cellula…

Principal investigator: prof. Grzegorz Władysław Węgrzyn

Uniwersytet Gdański

Call: OPUS 27, Panel: NZ2

103. The role of gut microbiota in the treatment of epilepsy: experimental studies

Principal investigator: prof. Piotr Wiktor Wlaź

Uniwersytet Marii Curie-Skłodowskiej w Lublinie

Call: OPUS 27, Panel: NZ4

104. Can the bactericidal and immunomodulatory effects of ceragenins be used in the development of new methods of treating ac…

Principal investigator: Agata Aleksandra Lesiak

Uniwersytet Jana Kochanowskiego w Kielcach

Call: PRELUDIUM 23, Panel: NZ6

105. New functional MOF@hydroxyapatite composites for the treatment of bacterial bone infections

Principal investigator: Weronika Bodylska-Maj

Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

Call: PRELUDIUM 23, Panel: ST11

106. Molecular mechanisms underlying the liver injury induced by ulipristal acetate treatment

Principal investigator: Aleksandra Natalia Łupińska

Instytut Rozrodu Zwierząt i Badań Żywności PAN

Call: PRELUDIUM 23, Panel: NZ7

107. Early Intervention with mTOR Inhibitors for Neuropsychiatric Symptoms in Tuberous Sclerosis Complex: Unveiling Developme…

Principal investigator: prof. Ewelina Anna Knapska

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: DAINA 3, Panel: NZ4

108. Dietary treatment in genetic mouse model of autism.

Principal investigator: dr Bożena Joanna Kuźniewska

Uniwersytet Warszawski, Wydział Biologii

Call: OPUS 26, Panel: NZ4

109. Tumor viscoelasticity as a central player in glioblastoma treatment - towards mechanopharmacology

Principal investigator: dr hab. Katarzyna Pogoda

Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

Call: OPUS 26, Panel: NZ7

110. The application of Cell-on-a-chip microsystems to study the course and monitoring of the treatment of peripheral autoimm…

Principal investigator: dr Magdalena Natalia Flont

Politechnika Warszawska, Centrum Zaawansowanych Materiałów i Technologii CEZAMAT

Call: SONATA 19, Panel: ST4

111. MagZEObone: Smart Magnetic Biomaterials Based on Zeolites and ZIFs in Service of Humanity - Multifunctional Bone Healing…

Principal investigator: dr Jakub Kamil Matusiak

Politechnika Lubelska, Wydział Budownictwa i Architektury

Call: SONATA 19, Panel: ST5

112. Targeting adenylate kinase 4 (AK4) as a new paradigm in the treatment of non-small cell lung cancer: discovery and evalu…

Principal investigator: dr Magdalena Wujak

Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

Call: OPUS 26, Panel: NZ7

113. The effect of prolonged treatment with the new antipsychotics brexpiprazole and lumateperone on human liver function usi…

Principal investigator: dr Przemysław Jan Danek

Instytut Farmakologii PAN

Call: OPUS 26, Panel: NZ4

114. Synthesis and application of new mixed-mode materials to study the metabolism of drugs used in Poland for the treatment …

Principal investigator: dr hab. Sylwia Studzińska

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: OPUS 26, Panel: NZ7

115. Spatiotemporal control of growth factor release from porous composite scaffolds for chronic wound healing.

Principal investigator: dr Tomasz Marek Urbaniak

Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

Call: SONATA 19, Panel: NZ7

116. The influence of free and immobilized bacteriophages on a bacterial cellulose-based carrier on human cells and the possi…

Principal investigator: dr Anna Malwina Żywicka

Zachodniopomorski Uniwersytet Technologiczny w Szczecinie, Wydział Biotechnologii i Nauk o Zwierzętach

Call: SONATA 19, Panel: NZ3

117. How is meiotic TEX12 re-activated in cancer and can we exploit this in the clinic?

Principal investigator: dr Urszula Łucja Mcclurg

Instytut Biologii Medycznej PAN

Call: SONATA BIS 13, Panel: NZ3

118. The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain…

Principal investigator: dr Bartosz Sebastian Pomierny

Uniwersytet Jagielloński, Collegium Medicum

Call: SONATA BIS 13, Panel: NZ7

119. Nanoconjugates of lactoferrin for treatment of respiratory tract infections

Principal investigator: Martyna Małgorzata Janicka

Wojskowy Instytut Higieny i Epidemiologii im. gen. Karola Kaczkowskiego

Call: PRELUDIUM 22, Panel: NZ6

120. (Micro)RNA and informatics approaches for diagnosis, prognosis and treatment of Alzheimer's disease and Dementia

Principal investigator: dr hab. Agnieszka Fiszer

Instytut Chemii Bioorganicznej PAN

Call: JPND Call 2023, Panel: NZ3

121. Curdlan-based biomaterial as a nanostructure carrier for controlled and targeted drug delivery in the treatment of deep …

Principal investigator: dr Aleksandra Nurzyńska

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 22, Panel: NZ7

122. Multifunctional emulsion-based transporters for personalised cancer treatment

Principal investigator: prof. Ewa Dłuska

Politechnika Warszawska, Wydział Inżynierii Chemicznej i Procesowej

Call: OPUS 25, Panel: ST8

123. Amorphous Senolytics: A Breakthrough Approach in Senescence Modulation and Age-Related Disease Treatment

Principal investigator: Szymon Sip

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: PRELUDIUM 22, Panel: NZ7

124. Bigels with controlled release of hydrophilic and hydrophobic therapeutic compounds as potential dressings in the treatm…

Principal investigator: dr hab. Monika Gosecka

Centrum Badań Molekularnych i Makromolekularnych PAN

Call: OPUS 25, Panel: ST11

125. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

Principal investigator: Patryk Pyka

Uniwersytet Jagielloński, Collegium Medicum

Call: PRELUDIUM 22, Panel: NZ7

126. Chiral hybrids of quinones and quinols with double anticancer and antimicrobial activity against drug-resistant pathogen…

Principal investigator: prof. Ryszard Józef Ostaszewski

Instytut Chemii Organicznej Polska Akademia Nauk

Call: OPUS 25, Panel: NZ7

127. The Role of the Mitochondrial Unfolded Protein Response (UPRmt) in Endothelial Function: a Possible Novel Target for the…

Principal investigator: Sylwester Tycjan Mosiołek

Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)

Call: PRELUDIUM 22, Panel: NZ7

128. Potential of TH cell profiling in personalized multiple sclerosis treatmentplanning.

Principal investigator: dr hab. Katarzyna Donskow-Łysoniewska

Uczelnia Łazarskiego

Call: OPUS 24, Panel: NZ7

129. Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed wit…

Principal investigator: dr Łukasz Kuryk

Narodowy Instytut Zdrowia Publicznego - Państwowy Zakład Higieny (NIZP - PZH)

Call: SONATA 18, Panel: NZ7

130. Hybrid materials responsive to external stimuli for local drug delivery in endometriosis treatment - analysis of selecte…

Principal investigator: dr Olga Urbanek-Świderska

Instytut Podstawowych Problemów Techniki Polska Akademia Nauk

Call: SONATA 18, Panel: ST5

131. The effect of maternal treatment with metformin in pregnancy and lactation on programming metabolic adverse conditions i…

Principal investigator: dr hab. Monika Słupecka-Ziemilska

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Call: SONATA BIS 12, Panel: NZ7

132. Flexible, stretchable and antibacterial curdlan-tannin dressing for the prevention and treatment of infected wounds - in…

Principal investigator: dr Anna Maria Michalicha

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 21, Panel: NZ7

133. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu…

Principal investigator: prof. Władysława Anna Daniel

Instytut Farmakologii PAN

Call: OPUS 23, Panel: NZ7

134. Smart tissue engineering to change the paradigm of diabetes treatment

Principal investigator: dr Anna Czarna

Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

Call: OPUS 23, Panel: NZ7

135. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

Principal investigator: dr Katarzyna Anna Szczepańska

Instytut Farmakologii PAN

Call: OPUS 23, Panel: NZ7

136. The role of impaired autophagy and peroxisome function in NAFLD development and their targeted recovery for improved eff…

Principal investigator: prof. Mariusz Roman Więckowski

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 22 (LAP), Panel: NZ3

137. Novel Point-of care-diagnostic devices for monitoring the concentration of lithium and creatinine in patients during the…

Principal investigator: dr Justyna Zofia Paluch

Uniwersytet Jagielloński, Wydział Chemii

Call: SONATA 17, Panel: ST4

138. New post-treatment strategy against stroke and perinatal asphyxia – a novel approach based on a selective activation of …

Principal investigator: dr hab. Agnieszka Wnuk

Instytut Farmakologii PAN

Call: SONATA 17, Panel: NZ7

139. Development of phage-based tool with the potential to treat antibiotic-resistant gonorrhea

Principal investigator: dr hab. Monika Julita Adamczyk-Popławska

Uniwersytet Warszawski, Wydział Biologii

Call: PRELUDIUM BIS 3, Panel: NZ6

140. 3D printing as a tool to obtain transdermal microneedle systems with improved efficiency in the treatment of depressive …

Principal investigator: prof. Tomasz Zbigniew Osmałek

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: SONATA BIS 11, Panel: NZ7

141. Novel hope for diseased joints: a polymer-based treatment to promoteregenerative strategies for patients with osteoarthr…

Principal investigator: Marta Kędziora

Instytut Farmakologii PAN

Call: PRELUDIUM 20, Panel: NZ7

142. Novel combination therapies of pulmonary arterial hypertension targeting blockade of peripheral cannabinoid CB1 receptor…

Principal investigator: prof. Barbara Malinowska

Uniwersytet Medyczny w Białymstoku

Call: OPUS 21, Panel: NZ7

143. Experiencing a disease and a treatment process in Greek non-medical sources in the Classical period and Roman times

Principal investigator: Aneta Liwerska-Garstecka

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Historii

Call: PRELUDIUM 20, Panel: HS3

144. Utilizing microbial metabolites for multiple sclerosis treatment

Principal investigator: dr Tomasz Piotr Wypych

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: OPUS 21, Panel: NZ6

145. Blocking the TNF-TNFR2 interactions as a novel approach to the ovarian carcinoma treatment

Principal investigator: prof. Sylwia Anna Rodziewicz-Motowidło

Uniwersytet Gdański, Wydział Chemii

Call: OPUS 21, Panel: NZ7

146. Impact of pharmacogenetic profiles on depression treatment outcomes

Principal investigator: dr Małgorzata Maria Borczyk

Instytut Farmakologii PAN

Call: SONATINA 5, Panel: NZ2

147. Does tormentil tincture (Tormentillae tinctura) support the therapy of leaky gut syndrome?

Principal investigator: dr Aleksandra Karolina Kruk

Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny

Call: SONATINA 5, Panel: NZ7

148. Tryptophan Metabolites and their Metal Complexes as new drugs for Colorectal Cancer Treatment and Human Gut Microbiota R…

Principal investigator: prof. Beata Izabella Godlewska-Żyłkiewicz

Uniwersytet w Białymstoku, Wydział Chemii

Call: OPUS 20, Panel: ST4

149. Harnessing gut microbiota-derived metabolites to combat acute respiratory distress syndrome

Principal investigator: dr hab. Tomasz Piotr Wypych

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

Call: SONATA 16, Panel: NZ6

150. New generation teranostatic nanocarriers for detection, diagnosis andneuroprotective treatment of ischemic stroke brain …

Principal investigator: prof. Piotr Warszyński

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Call: OPUS 20, Panel: NZ7

Projects search